Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs SHPAX overlap: 24% of top holdings shared

Bottom line

How much do IBB and SHPAX overlap?

24% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 34.1% of IBB's assets and 33.2% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.

IBB holds far more positions (254 vs 29), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IBBSHPAX
Weight overlap (top 25)24%
Shared holdings8
Weight in shared holdings34.1%33.2%
Total positions25429
Expense ratio0.44%3%
Holdings as ofSep 30, 2025May 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Holdings IBB and SHPAX have in common

Holding% of IBB% of SHPAXOverlap
Vertex Pharmaceuticals, Inc.7.66%3.36%3.36%
Gilead Sciences, Inc.7.52%3.94%3.94%
Amgen, Inc.7.50%5.04%5.04%
Regeneron Pharmaceuticals, Inc.5.70%3.93%3.93%
United Therapeutics Corp.1.82%6.17%1.82%
Incyte Corp.1.62%2.89%1.62%
Medpace Holdings, Inc.1.16%3.37%1.16%
Exelixis, Inc.1.07%4.55%1.07%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Alnylam Pharmaceuticals, Inc. — 5.68%
  3. IQVIA Holdings, Inc. — 3.18%
  4. Argenx SE — 3.15%
  5. Insmed, Inc. — 2.95%
  6. Mettler-Toledo International, Inc. — 2.49%
  7. Natera, Inc. — 2.11%
  8. BeOne Medicines Ltd. — 2.11%
  9. Biogen, Inc. — 2.03%
  10. Waters Corp. — 1.77%
  11. Illumina, Inc. — 1.41%
  12. Genmab A/S — 1.38%
  13. Neurocrine Biosciences, Inc. — 1.34%
  14. Ionis Pharmaceuticals, Inc. — 1.03%
  15. BioMarin Pharmaceutical, Inc. — 1.02%

Only in SHPAX

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. Mckesson Corp — 4.90%
  4. Lantheus Holdings Inc — 4.64%
  5. Novartis Ag — 4.50%
  6. Cencora Inc — 4.33%
  7. Johnson & Johnson — 3.91%
  8. National Healthcare Corp — 3.72%
  9. Merck & Company Inc — 3.63%
  10. Cigna Group (the) — 3.63%
  11. Intuitive Surgical Inc — 3.14%
  12. Bristol-myers Squibb Company — 3.07%
  13. Stryker Corp — 2.40%
  14. Medtronic Plc — 2.20%
  15. Eli Lilly & Company — 2.11%

Asset mix

Asset typeIBBSHPAX
Stocks99.8%99.0%
Cash & short-term funds13.4%1.6%

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Country mix

CountryIBBSHPAX
US98.6%86.1%
IE0.5%8.4%
CH2.7%4.5%
NL4.3%—
DK2.2%1.6%
GB1.0%—
KY0.9%—
DE0.7%—

Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)

Check another pair

FAQ

How much do IBB and SHPAX overlap?
About 24% by weight. 8 securities appear in both funds' top 25 holdings; they make up 34.1% of IBB's assets and 33.2% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IBB and SHPAX have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., United Therapeutics Corp..
Should I own both IBB and SHPAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IBB or SHPAX?
IBB is broader, with 254 positions versus 29 for SHPAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.